Polyamines are excellent stabilizers of triplex DNA. Recent studies in our laboratory revealed a remarkable structural specificity of polyamines in the induction and stabilization of triplex DNA. 1,3-Diaminopropane (DAP) showed optimum efficacy amongst a series of synthetic diamines in stabilizing triplex DNA. To utilize the potential of this finding in developing an anti-gene strategy for breast cancer, we treated MCF-7 cells with a 37mer oligonucleotide to form triplex DNA in the up-stream regulatory region of the c-myc oncogene in the presence of DAP. As individual agents, the oligonucleotide and DAP did not downregulate c-myc mRNA in the presence of estradiol. Complexation of the oligonucleotide with 2 mM DAP reduced c-myc mRNA signal by 65% at 10 u.M oligonucleotide concentration. In contrast, a control oligonucleotide had no significant effect on c-myc mRNA. The expression of c-fos oncogene was not significantly altered by the triplex forming oligonucleotide (TFO). DAP was internalized within 1 h of treatment; however, it had no significant effect on the level of natural polyamines. These data indicate that selective utilization of synthetic polyamines and TFOs might be an important strategy to develop anti-gene-based therapeutic modalities for breast cancer.
INTRODUCTION
Blocks of oligopurine.oligopyrimidine sequences are known to form triple helical DNA (triplex DNA) with oligonucleotides capable of binding through the major groove of the duplex DNA (1) (2) (3) (4) (5) . Therapeutic application of triplex DNA has come to the forefront as an anti-gene strategy recently. Triplex forming oligonucleotides (TFO) have been selectively utilized to suppress the transcription of growth regulatory genes, such as c-myc (6), interleukin-2 receptor (7), DNA polymerase a (8) , epidermal growth factor receptor (6) , dihydrofolatereductase (9) , Ha-ras (10) and a progesterone responsive gene (11) . A major impediment in advancing this technology has been the low stability of triplex DNA under physiological conditions (4, 5) . Based on our previous studies on the structural specificity of polyamines in DNA conformational dynamics, including the induction and stabilization of left-handed Z-DNA (12, 13) and protein-DNA interactions such as estrogen receptor-DNA recognition (14, 15) , we undertook a systematic analysis of the ability of natural and synthetic polyamines and their acetylated derivatives in stabilizing triplex DNA (16) . Our data showed that polyamines with a trimethylene (-CH2-CH2-CH2-) bridging region between the amino and imino groups exerted the maximal efficacy in stabilizing triplex DNA. Among the diamines, DAP increased the melting temperature (Tm) of a poly(dA).2poly(dT) triplex by 10°C compared to that exerted by its nearest lower or higher homologs.
In order to examine whether the selective stabilization of triplex DNA by polyamines could be used in suppressing the transcription of a disease-related gene, we undertook the present study on the transcription of the protooncogene c-myc in a hormone-responsive breast cancer cell line, MCF-7. A significantly higher level of c-myc gene expression is found in 25% of breast cancer tissues than that of normal tissues (17) . The c-myc gene is also an 'immediate early' gene that is transcriptionally stimulated in response to a variety of growth stimulatory agents, including estradiol, the female hormone that is believed to play a major role in the induction and progression of breast cancer (18) . The binding of estradiol with the estrogen receptor (ER) triggers a series of structural and conformational alterations in ER, transforming it to a form that binds to DNA with high affinity (18) (19) (20) . Recognition of the estrogen response element (ERE) in target genes by ER modulates the transcription of estrogen-responsive genes. The c-myc oncogene is stimulated by estradiol within the first 2 h of treatment in MCF-7 cells (18) . We previously used this cell line as a model for dissecting the growth regulatory mechanism(s) involving estrogens, anti-estrogens, polyamine homologs and polyamine biosynthetic inhibitors (22) (23) (24) (25) (26) .
The naturally occurring polyamines, putrescine, spermidine and spermine, are known to play an important role in cell proliferation and differentiation (27, 28) . Cellular polyamine levels are exquisitely regulated by growth stimulatory and inhibitory agents (29) . A major portion of intracellular polyamines is believed to exist in * To whom correspondence should be addressed association with negatively charged cellular macromolecules, such as nucleic acids. The concentration of polyamines available for regulatory interactions is believed to be in the uM-mM range (30) . Exogenous polyamines and their analogs are readily transported into the cell (31, 32) . Thus, synthetic polyamines such as DAP could be utilized to stabilize triplex DNA in vivo, provided their effect on polyamine homeostasis is limited. In the present investigation, we studied the effect of a TFO to alter the expression of c-myc gene in the presence of a synthetic polyamine. Our results showed that polyamine complexation facilitated the effect of TFO in suppressing c-myc mRNA levels under conditions at which endogenous polyamine levels are not significantly affected.
MATERIALS AND METHODS

Chemical and reagents
Putrescine.2HCl, spermidine.3HCl, spermine.4HCl, DAP.2HC1 and 1,6-diaminohexane.2HCl were purchased from Sigma Chemical Co. (St Louis, MO). 1,3-diaminopropane was obtained as a free amine from Aldrich Chemical Co. (Milwaukee, WI), converted to its hydrochloride and purified by re-crystallization from ethanol, as previously described (33) . Polyamine solutions were analyzed by HPLC and no impurities were detected. Estradiol was obtained from Sigma, dissolved in absolute ethanol as a 10 ^M stock solution and the culture dishes received a final concentration of 4 nM. Dansyl chloride was purchased from Pierce Chemicals (Rockfort, IL) as a concentrated solution in acetone. Chemicals for buffers and other reagents were analytical grade from Sigma or Aldrich.
The oligonucleotide capable of forming triplex DNA (6) at the promoter region of c-myc gene (Oligo I) and a control sequence (6) with the same base composition, but incapable of forming triplex DNA (Oligo II) were obtained from Oligos, Etc. (Wilsonville, OR). We also obtained Oligo III and Oligo IV representing the c-myc promoter region to determine the effect of DAP on the Tm of triplex DNA. The sequence of these oligonucleotides are:
Tissue culture media, antibiotics and fetal bovine serum were purchased from Sigma or Gibco (Long Island, NY). Total RNA isolation was accomplished with TRI Reagent from Molecular Research Center (Cincinnati, OH). A 32 P-labeled fragment of the c-myc cDNA, the \-fos DNA probe and the reagents for Northern blot hybridization were obtained from Oncor (Gaithersburg, MD).
Cell culture MCF-7 cells were obtained from the American Type Culture Collection (Rockville, MD). Cells were maintained in Dulbecco's modified Eagle's medium (DMEM) with 100 ug/ml penicillin, 100 ug/ml streptomycin, 40 ug/ml gentamicin, 2 ug/rnl insulin, 0.5 mM sodium pyruvate, 10 mM non-essential amino acids, 2 mM L-glutamine and 10% fetal bovine serum (22) (23) (24) (25) (26) . In all experiments involving the effects of estradiol, we used phenol red-free DMEM because phenol red was reported to have weak estrogenic activity (34) . Fetal bovine serum was treated with dextran coated charcoal (DCC) to remove serum-derived estrogenic compounds.
RNA preparation and Northern blot hybridization Cells (2 x 10 6 ) were plated in 60 mm dishes and synchronized in the G1 phase of cell cycle by isoleucine starvation for 30-36 h. Our previous studies showed that 80% of cells were synchronized in the Gl phase by this treatment (22) . Medium was changed into that containing isoleucine and cells were treated with estradiol (4 nM) or estradiol + oligonucleotides. Cells were harvested at defined time periods and treated with TRI reagent in order to isolate total RNA. For experiments in exponential growth phase, 1 x 10 6 cells were plated in 60 mm dishes. Cells were allowed to grow for 48 h before the addition of estradiol and oligonucleotides. RNA was extracted with chloroform, precipitated from isopropanol and quantified by recording the absorbance at 260 run. Total RNA samples were separated by agarose (1%) gel electrophoresis under denaturing conditions. Ethidium bromide (50 ug/ml) was added to samples immediately before loading. The gel and running buffer contained 2.2 M formaldehyde, 50 mM morpholinopropanesulfonic acid (MOPS), 10 mM sodium acetate and 1 mM EDTA (pH 7.0). The integrity of the 18S and 28S bands of the extracted RNA indicated that RNA molecules have not degraded during the extraction process. RNA was transferred onto a nylon membrane by the Maniatis procedure (35) adapted for the Probetech 2 automated transfer system (Oncor).
Hybridization conditions and washing procedures were optimized using standard protocols (23) . The specific activity of the cDNA probe was ~10 8 c.p.m./ug DNA. Pre-hybridization was for 1 h using Hybrisol I (Oncor) containing 50% formamide and other salts, as described by Maniatis etal. (35) . Hybridization was conducted in the same buffer at 45°C for 16 h. Filters were washed two times with a buffer containing 0.1 x SSC and 0.1% SDS at 22°C for 15 min. Subsequently, filters were washed for 1 h at 52°C in the same washing buffer. Washed filters were blotted on a paper towel, exposed to Kodak X-Omat AR film for 24-72 h at-70°C and then developed. A lightly exposed film was used for scanning the intensity of the bands using a Bio-Rad GS-670 Imaging densitometer. The radioactive DNA probes were removed by boiling the filter in RNase-free water and the filter was re-hybridized using 32 P-labeled glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (Clonetech, Palo Alto, CA).
Polyamine assay
Cells (2-3 x 10 6 ) were harvested from culture, washed with phosphate buffered saline (PBS) and collected by centrifugation. Cells were then treated with 300 ul of 8% sulfosalicylic acid and sonicated for 15 s in ice. The solution was incubated in ice for 1 h and centrifuged at 10 000 g for 5 min using a microfuge to remove the precipitated protein. Intracellular polyamine levels were determined by HPLC after converting them to their dansyl derivatives by a previously described procedure (24) . 1,6-diaminohexane was used as an internal standard. HPLC was performed with a Hewlett Packard HP 1090 Liquid Chromatograph using HP 1046A Programmable Fluorescence Detector. 
Tm measurements
Oligo I, Oligo III and Oligo IV were dissolved separately in water. The three strands were then mixed in 1:1:1 molar ratio in 10 mM cacodylate buffer (pH 7.5) or 10 mM Tris-HCl buffer (pH 7.5) in the presence or absence of DAP. The solutions were boiled for 10 min and allowed to attain equilibrium at 22°C for 16 h.
Absorbance versus temperature profiles were recorded using a Perkin Elmer Lambda 2 spectrophotometer (16) . The temperature of the five-cell holder was controlled by a thermoelectrically regulated programmer interfaced to an IBM PS2 computer. Melting profiles were obtained by increasing the temperature at a rate of 0.5 °C per min with the absorbance and temperature being recorded every 30 s. Melting temperature was taken as the temperatures corresponding to half dissociation of the complexes and the reproducibility was within ±0.5 °C. The first derivative, dA/dT (where A is absorbance and T is temperature), of the melting curve was computer generated and was also used for determining melting temperature of the triplex (7mi) and duplex (Trr\2) forms of the oligonucleotide and these two methods were consistent within 0.5 °C. Figure 1 shows the effect of 4 nM estradiol on c-myc mRNA levels in MCF-7 cells progressing in cell cycle. We used 4 nM estradiol in these experiments because previous cell growth and gene regulation studies were conducted under these conditions (22, 23, 25) . There was no significant increase in cell proliferative response at higher concentrations of estradiol. At the 0 h time point, the medium was changed to that containing isoleucine and estradiol (in ethanol) and was added to triplicate dishes. Equivalent volume of ethanol was added to control cells. As is evident from Figure 1 A, estradiol stimulated c-myc mRNA at 30 min after its addition. Increased c-myc mRNA was also observed at the 60 and 90 min time points. RNA gel picture (Fig. IB) showed that equivalent amount of RNA was loaded in all lanes. Further analysis of the membrane with the GAPDH probe also showed that the observed differences in c-myc mRNA levels were not due to differences in transfer efficiency (results not shown). Densitometric scanning and normalization with GAPDH showed 1-3) or 1 h (lanes 4-6) after the addition of estradiol or estradiol + DAP.
RESULTS
2-to 4-fold increase in the intensity of the c-myc mRNA band in estradiol-treated cells compared to that in untreated control.
We next examined the effect of Oligo I on the expression of c-myc mRNA at various time points (Fig. 2A) . Gl synchronized cells were treated with estradiol or estradiol + Oligo I. c-myc mRNA induction was observed at the 30 and 60 min time points. After normalization of the blot intensity with that of GAPDH, estradiol induction of c-myc mRNA was in the 1.5-to 2-fold range. Addition of 10 uJVl TFO did not suppress the c-myc mRNA level at 30 and 60 min after its addition. In contrast, a 30% increase in the level of c-myc mRNA was observed. The reason for this increase is not clear, but it is possible that the c-myc mRNA stability might have changed in the presence of the TFO.
The effect of DAP was also studied as a single agent on the transcription of c-myc oncogene in MCF-7 cells (Fig. 2B) . We used 2 and 5 mM concentrations of the DAP in these experiments. Previous physical chemical studies showed that these concentrations were effective in stabilizing poly(dA).2poly(dT) triplex (16) . At 2 mM concentration, DAP had no marked effect on c-myc mRNA; however, in the presence of 5 mM DAP, a 2-to 3-fold increase was found, compared to the control. This increase might be due to enhanced transcription of c-myc mRNA since natural polyamines, such as spermidine and spermine, enhanced c-myc mRNA level (36) . To optimize conditions of reduced c-myc expression, we chose 2 mM DAP in subsequent experiments. Figure 3 A shows our results on the effect of a combination of DAP and Oligo I on c-myc mRNA level in MCF-7 cells in the presence of estradiol. In contrast to the stimulatory effect of Oligo I as an individual agent, the combination of Oligo I and DAP suppressed the transcription of c-myc oncogene at the 1 h time point (lane 5). Densitometric scanning showed a 65% decrease in c-myc mRNA level compared to that in estradiol-treated (lane 2) cells. As shown in Figure 3B , addition of 10 |jM control oligonucleotide (Oligo II) and 2 mM DAP showed only a minor change (15%) in c-myc mRNA level. These results indicate that suppression of c-myc gene expression by polyamine-complexed Oligo I is specific to the triplex forming nucleotide sequences and is not a non-specific effect of the oligonucleotide.
In the next series of experiments, we examined the dose-dependent effect of Oligo I on c-myc expression (Fig. 4) . In the presence of 2 mM DAP, increasing concentrations of Oligo I exerted a dose-dependent suppression of c-myc gene expression. After normalization with GAPDH signal, c-myc mRNA levels were 22, 50 and 84%, respectively, lower than that of untreated control in the presence of 5,10 and 20 (iM concentrations of Oligo I. We also determined the expression of another estradiol-induced gene, c-fos in the presence of oligo I and DAP (Fig. 4) . The normalized c-fos hybridization signal was only reduced by 5, 13 and 18%, respectively, in the presence of 5, 10 and 20 uM Oligo I and 2 mM DAP.
We conducted the majority of our experiments using synchronized cells in order document the sequential changes in cell growth-and cell cycle-regulatory genes as a part of our ongoing studies on estrogenic regulation of cell cycle in breast cancer. We have, however, determined the effect of DAP (2 mM) and Oligo I (10 (J.M) in logarithmically growing cells and found a similar effect of a combination of Oligo I and DAP on c-myc mRNA.
Quantification of the yield of total RNA in different treatment protocols varied from 42 to 63 ug/dish. There was no pattern suggestive of increased degradation after Oligo I treatment, but a general increase in total RNA (10-30%) occurred in the presence of DAP and Oligo I, compared to controls. These results suggest that the effect of Oligo I + DAP on the expression of c-myc gene is not due to non-specific activation of ribonuclease.
A facile transportation of polyamines within MCF-7 cells has been found by us and others (25) . To examine whether the internalization of DAP is affected by Oligo I, we determined intracellular polyamine levels using a sensitive HPLC technique. Wrharvested cellsireated with DAPin the presence and absence of Oligo I at 0, 0.5, 1 and 4 h for polyamine assay. As shown in Figure 5 , DAP was internalized within 0.5 h of its addition to cell culture medium in the absence of Oligo I. DAP levels peaked within 1 h of treatment. However, there was a delay in the internalization of DAP in cells treated with this polyamine in combination with Oligo I. Measurable levels of intracellularDAP was found at 1 h of treatment. At this point, DAP concentration was 50% lower than that found in cells treated with this diamine alone. There was no marked increase in DAP levels beyond the 1 h time point in both cases.
We next examined whether the gene regulatory effects of DAP in combination with Oligo I is due to depletion of natural polyamines. Our results, presented in Figure 6 , showed no significant difference in polyamine levels in DAP-treated cells in the presence or absence of Oligo I. Thus DAP has no major effect on polyamine biosynthesis or degradation, under conditions at which it could suppress c-myc gene expression in association with Oligo I.
We also examined whether DAP could stabilize triplex formation in vitro in Oligo I and the sequences of the promoter region of c-myc gene (Oligo III and Oligo IV) by 7m measurements. There was only one transition of the oligonucleotide complex in Tris buffer, in the absence of DAP (7m = 77°C). In contrast, in the presence of 0.5 mM DAP two sharp transitions corresponding to 7m ] at 80 °C and 7m2 at 97 °C were observed. From mixing experiments at different ratios, Tmi was assigned to triplex melting whereas 7m2 represented duplex melting. The increase in duplex 7m from 77 to 97° C is a polyamine effect as reported earlier (16) . In experiments conducted in 10 mM cacodylate buffer, however, there was only one transition both in the presence and absence of DAP. The formation of triplex DNA in Tris buffer might be a consequence of the ability of bulky cations such as Tris to disrupt tetraplex formation in G-G rich oligonucleotides (37, 38) . These experiments clearly demonstrate the ability of diaminopropane to stabilize triplex DNA at the sequences present in the promotor region of the c-myc gene.
DISCUSSION
Results presented in this paper demonstrate that a TFO (Oligo I) complexed with DAP has a marked effect on suppressing the steady-state level of c-myc mRNA. Oligo I was selected to form triplex DNA at the promoter fegfon "of ~c-myc ^ncogene, as suggested from previous studies by other investigators (3, 6, 39) . Our in vitro 7m measurements confirmed the ability of Oligo I to form triplex DNA in the presence of DAP. A control oligonucleotide with the same nucleotide composition, but a sequence distribution not amenable to triplex DNA formation, was unable to alter c-myc mRNA level significantly. DAP was the most efficacious diamine in triplex DNA stabilization in our physical chemical studies (16) . As individual agents, Oligo I and DAP had a tendency to increase c-myc mRNA levels in MCF-7 cells. In contrast, up to 84% decrease in c-myc mRNA occurred by combining these two agents. Quantification of polyamine levels showed that the effect of DAP-complexed Oligo I was not a consequence of interference with the milieu of natural poly- amines within the cell. Thus, selective utilization of synthetic polyamines might be an important strategy to realize the potential of triplex DNA-based gene inactivation.
Several recent studies have attempted to utilize triplex DNAbased anti-gene strategy as a therapeutic approach for treating cancer and other diseases by selective inactivation of disease-related genes. DNase I foot-printing and gel mobility assays have shown triplex formation by Oligo I in the promoter region of c-myc (3, 6) . Down-regulation of c-myc by triplex formation has also been shown in HeLa cells (39) . In other studies, transcription of IL-2 receptor gene (7, 40) was down-regulated by a modified oligonucleotide targeted for triplex formation at the promoter region of this gene. In spite of these encouraging reports on the use of triplex DNA as an anti-gene strategy, oligonucleotide uptake and stability within cells remain highly variable between cell cultures systems and between laboratories (41). The successful suppression of c-myc mRNA in our system could be attributed to several factors: (i) the optimization of triplex stabilization for polyamine structure and concentration by physical chemical studies; and (ii) potential enhancement of oligonucleotide uptake in the presence of DAP, although further studies are needed to demonstrate this effect. Since peak induction of c-myc expression was observed within 1 h of addition of estradiol and this induction was found to be transient in both logarithmic and synchronized cells, we focused on the effects of Oligo I and DAP at this time point. The dynamics of c-myc induction and the stability of myc mRNA as well as the up-take and stability of the oligonucleotides might be important in understanding differences observed between this and other systems.
There was a decrease in the up-take of DAP in the presence of the oligonucleotide. Breast cancer cells have been reported to have a highly regulated polyamine transporter (42) . It is not known whether Oligo I utilizes this pathway for up-take. On the other hand, in the presence of Oligo I, DAP might be entering the cell through a much inefficient pathway associated with the up-take of Oligo I. Studies on changes in the internalization mechanisms of DAP and Oligo I as individual agents and in combination might provide important new insights on the function of proteins involved in polyamine and oligonucleotide transport.
Recent studies indicate that the effects of TFOs might also include other pathways of gene regulation. For example, specific proteins have been found to bind to triplex DNA/H-DNA and act as a transcriptional insulator (43) . Our in vitro studies indicated a high affinity binding of estrogen receptor to poly(dAdT).2poly(dA-dT) triplex in the presence of polyamines (44) . Furthermore, the oligonucleotide used in this study is rich in guanosine and the possibility of G.G hydrogen bonding and the formation of tetraplexes also exist (37, 38) . Tetraplex formation has been reported to be important in the anti-viral activity of certain oligonucleotides (45) . Thus further studies are needed to elucidate the precise mechanism of action of TFOs including the one used in these experiments. Our control experiments, especially that showing a lack of Oligo I + DAP effect on c-fos expression in MCF-7 cells, indicate that Oligo I might be acting at the c-myc promoter region through triplex DNA formation.
Strategies to circumvent problems of oligonucleotide stability include use of intercalating agents such as ethidium and berenil and the substitution of an abasic or polymeric linker (46) (47) (48) (49) . These modifications are likely to alter the conformational and configurational flexibility of the oligonucleotide and clamp the oligonucleotide within the major groove of double helical DNA. Alternatively, optimization of triplex stability might be achieved partly by variations in oligonucleotide length and sequence (50) . Our approach has been to use closely related homologs of the naturally occurring polyamines (16) . Addition of exogenous spermidine, spermine or their homologs are likely to be more toxic than putrescine or putrescine homologs as the higher polyamines are better substrates for polyamine oxidases that generate hydrogen peroxide and aldehydes as degradation products (51) . In other studies, we found that DAP had no toxic effect on the growth and immune response of normal cells (52) . An important advantage of using DAP in stabilizing triplex DNA is that this compound undergoes facile transportation within cancer cells (53) and the internalization of this polyamine has no significant effect on the well-orchestrated polyamine homeostasis mechanism(s) (Fig. 6) . Thus, the natural functions of polyamines are not affected by this synthetic diamine, at least at the early time periods. Since c-myc is an 'immediate early gene' activated in the early stages of cell cycle progression, the consequences of suppressing the expression of this gene should include blockade of cell cycle progression. Thus the use of this diamine in stabilizing triplex DNA might provide a good therapeutic window in gene specific therapy.
Breast cancer is a major public health problem in the Western world today, affecting one in eight women in the US. Despite extensive research during the past several decades, the death rate from this malady has shown only a slight increase. Results of our present study, in conjunction with our previous findings on the structural specificity of polyamines in stabilizing triplex DNA (16) , indicate a new approach of using selective homologs of the natural polyamines in developing an anti-gene strategy for breast cancer.
In summary, our results show that complexation of a triplex forming oligonucleotide with a polyamine might be a viable approach to realize the potential of triplex DNA-based anti-gene strategy for breast cancer treatment. This approach might have general utility in selective suppression of disease-related genes.
